Stay updated on Phase 2a Safety of MEDI8852 in Influenza Clinical Trial

Sign up to get notified when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The Locations section was updated to add state-level listings for California, Florida, Indiana, Louisiana, Michigan, Montana, North Carolina, Pennsylvania, Texas, and Utah, while old per-state location groupings were removed, accompanied by a new revision tag v3.3.3.
    Difference
    1.0%
    Check dated 2025-12-23T22:18:12.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Publications section now states items are automatically filled from PubMed and may not be about the study, with the revision labeled v3.3.2. The prior wording claiming automatic creation by ClinicalTrials.gov based on the NCT number was removed (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-25T11:52:27.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page no longer displays the government funding/operating status notice. This notice did not affect the study data, enrollment, or outcomes presented.
    Difference
    0.3%
    Check dated 2025-11-18T07:18:14.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page content regarding the study details appears unchanged, with only minor visual/UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:24:44.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating-status details (affecting transaction processing and inquiries). - Updated version to v3.2.0, removing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T05:56:38.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Version upgrade to v3.1.0 with removal of multiple drug-safety subtopics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a reorganization or narrowing of content.
    Difference
    0.4%
    Check dated 2025-09-29T03:13:17.000Z thumbnail image

Stay in the know with updates to Phase 2a Safety of MEDI8852 in Influenza Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 2a Safety of MEDI8852 in Influenza Clinical Trial page.